Patents by Inventor Ajit Saxena

Ajit Saxena has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060280817
    Abstract: The present invention relates to anticancer activity against hepatocellular carcinoma of an extract and fraction isolated from flowers of Butea monosperma. Particularly, this invention relates to anticancer activity against hepatocellular carcinoma of a composition containing markered flavonoid glycosides such as butrin and isobutrin in the range of 2 to 9% by weight, isolated from the flowers of Butea monosperma by extracting the flowers with polar solvent like ethanol, methanol, aqueous ethanol or water, removing fatty non-polar constituents by triturating the extract with solvents such as ethylene chloride, methylene chloride, chloroform or ethyl acetate, suspending the residue in water, extracting with n-butanol and freeze drying the aqueous part.
    Type: Application
    Filed: May 25, 2006
    Publication date: December 14, 2006
    Inventors: Ajit Saxena, Bishan Gupta, Bal Kapahi, Shanmugavel Muthiah, Dilip Mondhe, Baleshwar, Ghulam Qazi, Vijay Kumar, Ganeshan Mathan
  • Publication number: 20060134762
    Abstract: The present invention relates to a novel source of microorganism for production of Camptothecin and related camptothecinoids. The invention also discloses its isolation, screening for Camptothecin production, growth, fermentation requirements and chemical analysis of Camptothecin (camptothecinoids).
    Type: Application
    Filed: December 21, 2004
    Publication date: June 22, 2006
    Inventors: Satish Puri, Vijeshwar Verma, Touseef Amna, Geeta Handa, Vinay Gupta, Neelam Verma, Ravi Khajuria, Ajit Saxena, Ghulam Qazi, Michael Spiteller
  • Patent number: 6214849
    Abstract: The present invention discloses the use of nicorandil in treatment of male impotency and female sexual dysfunction. Nitric ester of N-(2-hydroxyethyl) nicotinamide or nicorandil, as it is better known is known as a drug for treatment of circulatory diseases. It is a pyridine derivative. Several clinical tests performed on male patients suffering from impotency including severe penile erectile dysfunction or female patients suffering from female sexual arousal dysfunction consistently showed excellent results. There was not a single instance of any of side effects or other symptoms of toxicity or deaths due to myocardial infarctions as was the case with other drugs including pyrazolopyrimidones compounds.
    Type: Grant
    Filed: June 4, 1999
    Date of Patent: April 10, 2001
    Assignee: Lupin Laboratories Limited
    Inventors: Ajit Saxena, Dhananjay Sadashiv Bakhle